Paper17190864
Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.
Sarwar N and 8 others. Circulation, 2007. Cited by 1,106 papers, by iCite.
Cite this record
ConductScience Library. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Papers, record 17190864. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17190864
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Disease | Major topic |
| Triglycerides | Major topic |
| Case-Control Studies | |
| Humans | |
| Incidence | |
| Prospective Studies | |
| Risk Factors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0401527 | Medical Research Council | United Kingdom | PubMed | |
| G0501792 | Medical Research Council | United Kingdom | PubMed | |
| MC_U106179471 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03906539 | Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia | Results |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 18417063 | Triglycerides and the risk of coronary artery disease. | https://conductscience.org/library/papers/18417063 |
Source PubMed
Cited by539
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42842103 | Triglyceride-related metabolic indices and low relative muscle mass: a cross-sectional analysis of SMILE and NHANES. | Endocrine | 2026 | https://conductscience.org/library/papers/42842103 | PubMed |
| 42515752 | Unmet Cardiovascular Risk Beyond LDL-C: A Perspective on Managing Residual Cardiovascular Risk. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515752 | PubMed |
| 42474848 | Triglyceride-Rich Lipoproteins and ASCVD: Evidence for Causality and Challenges in Therapeutic Translation. | Curr Atheroscler Rep | 2026 | https://conductscience.org/library/papers/42474848 | PubMed |
| 42466363 | Therapeutic Potential of Alternating Magnetic Fields for Normalizing Blood Parameters and Restoring Renal, and Cardiac Function in Diabetic Mice. | Avicenna J Med Biotechnol | 2026 | https://conductscience.org/library/papers/42466363 | PubMed |
| 42243955 | Hypertriglyceridaemia and its multifaceted mechanisms driving atherosclerotic cardiovascular disease. | Lipids Health Dis | 2026 | https://conductscience.org/library/papers/42243955 | PubMed |
| 42220054 | Association of triglyceride-driven residual atherosclerotic risk with carotid stiffening assessed using ultrafast ultrasound imaging in individuals with hypertriglyceridemia. | Ultrasonography | 2026 | https://conductscience.org/library/papers/42220054 | PubMed |
| 42189912 | MR2G: A novel framework for causal network inference using GWAS summary data. | PLoS Genet | 2026 | https://conductscience.org/library/papers/42189912 | PubMed |
| 42152161 | Carbohydrate-dependent interaction between AMY1A/AMY2B copy number variation and APOA5 rs651821 associated with hypertriglyceridemia in Korean middle-aged adults. | BMC Nutr | 2026 | https://conductscience.org/library/papers/42152161 | PubMed |
| 42022002 | Diagnosing and treating fatty liver disease: strategies for hepatocellular carcinoma and cardiovascular disease prevention. | Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/42022002 | PubMed |
| 41991780 | FIB-4 predicts coronary disease and early outcomes in unstable angina pectoris. | Intern Emerg Med | 2026 | https://conductscience.org/library/papers/41991780 | PubMed |
| 41824431 | Effect of iodine nutrition on blood glucose and blood lipid levels in different regions: Based on quantile regression. | PLoS One | 2026 | https://conductscience.org/library/papers/41824431 | PubMed |
| 41676432 | 2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk? | Arch Med Sci | 2025 | https://conductscience.org/library/papers/41676432 | PubMed |
| 41508688 | Explainable machine learning framework using visceral adiposity index to predict cardiorenal syndrome: a survey-weighted NHANES study with SHAP interpretation. | Ren Fail | 2025 | https://conductscience.org/library/papers/41508688 | PubMed |
| 41495770 | Combination therapy of statin and acipimox versus statin monotherapy in acute myocardial infarction with hypertriglyceridemia: a multicenter propensity score-matched analysis. | Lipids Health Dis | 2026 | https://conductscience.org/library/papers/41495770 | PubMed |
| 41345827 | Machine learning-based prediction of atherosclerotic cardiovascular disease risk in adults with diabetes or prediabetes. | BMC Cardiovasc Disord | 2025 | https://conductscience.org/library/papers/41345827 | PubMed |
| 41339782 | Prioritizing acquired risk factors of atherosclerotic cardiovascular disease according to genetic predisposition: implications for precise prevention. | BMC Cardiovasc Disord | 2025 | https://conductscience.org/library/papers/41339782 | PubMed |
| 41169445 | Association between a reduction in triglyceride levels and risk of cardiovascular events. | Am Heart J Plus | 2025 | https://conductscience.org/library/papers/41169445 | PubMed |
| 41165750 | Myocardial lipin1 protects the heart against ischemic injury by preserving lipid homeostasis. | JCI Insight | 2025 | https://conductscience.org/library/papers/41165750 | PubMed |
| 41148476 | Mendelian randomization combined with real-world study reveals that Streptococcus anginosus exacerbates dietary triglyceride metabolism disorders in obese mice. | World J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/41148476 | PubMed |
| 41112504 | Stima dei pazienti potenzialmente eleggibili alla terapia con icosapent etile in Italia mediante revisione dei dati di letteratura. | Glob Reg Health Technol Assess | 2025 | https://conductscience.org/library/papers/41112504 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| ATORVASTATIN | CHEMBL1487 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1487 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17190864
GET https://conductscience.org/api/papers/v1/17190864/cited_by?page=2